Loading
SP
Solis Pharma US, Inc. Stock: price and insider trades · United States
Solis Pharma US, Inc.: what insiders have been doing
Every trade that managers of Solis Pharma US, Inc. disclose to SEC (Form 4) is tracked on this page. Solis Pharma US, Inc. has had no insider filing for more than a year; the last one goes back to 24 September 2015.
Our records for Solis Pharma US, Inc. go back to 2014, with no purchases and 4 sales on the open market in total.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€21B
4 ops. · all time
Last declaration on 24 September 2015
Declarations4 total
9.8 shares@ US$980.00common stockSEC:0001021432-15-000903:0
9,800,000 shares@ US$980.00common stockSEC:0001021432-14-000084:0
9,800,000 shares@ US$980.00common stockSEC:0001021432-14-000083:0
9,800,000 shares@ US$980.00common stockSEC:0001021432-14-000085:0
4 of 4 declarations
About Solis Pharma US, Inc.
Solis Pharma US, Inc. is a pharmaceutical company focused on developing innovative treatments. It is listed on the XNAS market.
